Clin Osteol 2007; 12(4): 152-155

Osteomalacia in a patient with unrecognized coeliac diseaseCase reports

L. Franeková

Coeliac disease, involving the mucosa of the small intestine, is manifested by malabsorption syndrome of various severity. This auto­ immune disease is caused by the gliadin fraction of gluten in genetically predisposed individuals. The diagnosis of coeliac disease is made by biopsy detection of intestinal changes. Typically, these are various degrees of mucosal atrophy and round-cell infiltration, an increased number of intraepithelial lymphocytes and crypt hyperplasia. In the patients' serum, gliadin antibodies (AGA), endomysial antibodies (EmA) and tissue tranglutaminase antibodies (anti t-TG) are detected. Examination of the antibodies may detect even patients with silent or latent forms of the disease who have no or just uncharacteristic dyspeptic difficulties and osteoporosis or osteo­ malacia that cannot be explained by other causes. The management is based on gluten-free diet and replacement therapy. We present an unusual case report of a 72-year-old female patient with osteomalacia and multiple fractures, suffering from lifelong di­ arrhoea. The examination of antibodies and subsequent biopsy of the duodenal mucosa confirmed florid coeliac disease. The discus­ sion focuses on the individual types of antibodies - their sensitivity, specificity and effective utilization for screening.

Conclusions: The case report confirms the fact that even active forms of the disease may remain undetected until the advanced age. Although the definitive diagnosis of coeliac disease can only be made after histological assessment of the intestinal mucosa, the exa­ mination of antibodies (EmA, anti t-TG) is highly sensitive and specific for this disease. Because of the risk of osteoporosis-related frac­ tures and more frequent malignancies of the gastrointestinal tract, screening with these antibodies is recommended in patients with osteoporosis reporting diarrhoea orjust dyspeptic difficulties, in osteoporotic men and premenopausal women, in osteoporotic patients with sideropenic anaemia of unknown aetiology, and in relatives of coeliac patients.

Keywords: osteomalacia, osteoporosis, coeliac disease, antibodies

Published: December 11, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Franeková L. Osteomalacia in a patient with unrecognized coeliac disease. Osteologický bulletin. 2007;12(4):152-155.
Download citation

References

  1. Kagnoff MF. Overview 2005;128,Suppl 1:10-18. Go to original source...
  2. Heel DA, West J. Recent advances in coeliac disease. Gut 2006;55:1037-1046. Go to original source...
  3. Rewers M. Epidemiology of celiac disease: What are the prevalence, incid and progression of celiac disease? Gastroenterology 2005;128,Suppl 1:47-51. Go to original source...
  4. Dewar DH, Ciclitira PJ. Clinica enterology 2005;128,Suppl 1:19-24. Go to original source...
  5. Green PHR. The many faces of celiac disease: clinical presentation of celiac di­ sease: clinical presentation of celiac disease in the adult population. Gastro rology 2005;128,Suppl 1:74 - 78. Go to original source...
  6. Bushara KO. Neurologic manifestation of celiac disease. Gastroenterology 2005;128,Suppl 1:92-97. Go to original source...
  7. Holden W, Orchard T, Wordsworth P. Enteropathic arthritis. Rheum Dis Clin N Am 2003;29:513-530. Go to original source...
  8. Tata LJ, Card TR, Logan RFA,et al. Fertility and pregnancy - related events women with celiac disease: a population - based cohort study. Gastroenterology 2005;128, Suppl 1:849-855. Go to original source...
  9. Rostom A, Dubé C, Cranney A, et al. The diagnostic accurancy of serologic tests for celiac disease: asystematic review. Gastroenterology 2005;128,Suppl 1:38-46. Go to original source...
  10. Hill ID. What are the sensitivity and specificity of serologic tests for celiac d ase? Do sensitivity and specificity vary in different populations? Gastroenterolo­ gy 2005;128,Suppl 1:25-32. Go to original source...
  11. Kocna P, Vaníčková Z, Perušičová J, Dvořák M. Tissue transglutaminase - sero­ logy markers for celiac disease. Clin Chem Lab Med 2002;40(5):485-492. Go to original source...
  12. Keaveny AP, Freaney R, McKenna MJ, et al. Bone remodeling indices and se­ condary hyperparathyroidism in celiac disease. Am J Gastroenterol 1996;91(6): 1226-1231.
  13. Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lym­ phomas and other cancers. Gastroenterology 2005;128,Suppl 1:79-86. Go to original source...
  14. Holmes GK, Prior P, Lane MR, et al. Malignancy in celiac disease - efect of glu­ ten free diet. Gut 1989; 30: 333-338. Go to original source...
  15. Collin P. Should adults be screened for celiac disease? What are the benefits and harms of screening? Gastroenterology 2005;128,Suppl 1:104-108. Go to original source...
  16. Ilavská A, Paulovičová E, Mikulecký M. Význam vyšetrenia serologických markerov u pacientov s celiakiou. Čas Lék čes 2002;141(15):487-490.
  17. Pietzak MM. Follow up of patient with celiac disease: achieving compliance with treatment. Gastroenterology 2005;128,Suppl 1:135-141. Go to original source...
  18. Kupper S. Dietary guidelines and implementation for celiac disease. Gastroente­ rology 2005;128,Suppl 1:121-127. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.